Standardization

Nanomedicine - Publication in STP Pharma Pratiques

In 2022, LNE organized a workshop to bring together nanomedicine players and high-level speakers to address the characterization and testing issues involved in bringing innovations in this field to market and patients (https://www.lne.fr/fr/actualites/nanomedecine-caracterisation-retours-workshop-2022). This event was intended to be the starting point for the Nanomedicine Working Group of the NanoMesureFrance Association. It...
Read More

Agglomeration and aggregation of nanoparticles

The question of nanoparticle agglomeration and aggregation is important for many issues, from product performance and associated quality control, to production process optimization, risk assessment and associated regulatory requirements. In France, the mandatory annual declaration of substances in the nanoparticulate state (R-Nano register) requires information on the state of aggregation of nanoparticles...
Read More

First meeting of the Strategic Think Tank!

On Wednesday April 3, the NanoMesureFrance Association held the first meeting of its Strategic Reflection Committee, attended by representatives of key stakeholders in the scope of the Association's reflections and actions. This committee is intended to act as the Association's interface, and includes representatives of its founding members (France Chimie, FEBEA & LNE), a representative for each working group, as well as representatives or exp...
Read More